Latest filing published 17 Oct 2025 for Heron Therapeutics, INC.. Read the official filing
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Rubric Capital Management LP discloses dealings in 5 companies, chiefly TherapeuticsMD, Inc., Radius Health, Inc. and Heron Therapeutics, Inc. /DE/. Between 8 December 2021 and 15 October 2025, the trades on record add up to 20 filings.
Market trades split into 12 purchases (€42.9M) and 4 sales (€966.5M). The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants. So far in 2025, the count stands at 1 purchase and 2 sales.
Half of the purchases are above €1.9M and half below. On 1 out of 12 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
On 17 October 2025 came the latest disclosure, a transaction in Heron Therapeutics, Inc. /DE/. The most recent open-market purchase was published on 12 August 2025, 432 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations